Form 8-K - Current report:
SEC Accession No. 0001493152-21-021876
Filing Date
2021-09-02
Accepted
2021-09-02 16:15:59
Documents
17
Period of Report
2021-09-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45011
2 ex10-1.htm EX-10.1 332472
3 ex99-1.htm EX-99.1 18421
4 ex99-1_001.jpg GRAPHIC 24886
5 ex99-1_002.jpg GRAPHIC 11935
  Complete submission text file 0001493152-21-021876.txt   753025

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hrow-20210901.xsd EX-101.SCH 3747
7 XBRL DEFINITION FILE hrow-20210901_def.xml EX-101.DEF 28160
8 XBRL LABEL FILE hrow-20210901_lab.xml EX-101.LAB 37404
9 XBRL PRESENTATION FILE hrow-20210901_pre.xml EX-101.PRE 26775
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5544
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 211233421
SIC: 2834 Pharmaceutical Preparations